Choosing Wisely in endometrial & cervix cancers: Medical therapy
Dr Erik Sahai gives an overview of his talk at NCRI 2011 on cancer metastasis, the most life-threatening element of the disease. Dr Sahai proposes in his research that metastasis is the same process that drives the shaping and development of our body, but reactivated in a dangerous and potentially deadly way. The metastasised cells that spread through the body have an increased migratory property, an intrinsic resistance to therapy and an increased ability to spread.
By exploring the idea that metastasis is a reactivation of this natural process, Dr Sahai and his team aim to understand how metastasis begins and how it can be stopped.
Choosing Wisely in endometrial & cervix cancers: Medical therapy
ESMO 2024: Optimising the personalisation of prostate cancer treatment
The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma
ASCO 2024: Lung cancer highlights
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting